Prevention of catheter-related deep vein thrombosis with nadroparin in hemato-oncology patients treated with high dose chemotherapy.
Completed
- Conditions
- Clinical trial.
- Registration Number
- NL-OMON21969
- Lead Sponsor
- Academic Medical CenterMeibergdreef 91100 DD Amsterdam
- Brief Summary
J Thromb Haemost. 2007 Sep;5(9):1878-82.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
1. Central venous catheter;
2. Indication for high dose chemotherapy
(AML, ALL, MDS-RAEB, MM);
Exclusion Criteria
1. Current anticoagulant therapy;
2. Allergy for contrastmedia;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Asymptomatic and symptomatic catheter-related deep vein thrombosis proven by ultrasound or venography.
- Secondary Outcome Measures
Name Time Method 1. Catheter-related infections;<br /><br>2. Bleeding complications.